Futures Marginally Higher as Geopolitical Risks Rise
Futures are marginally higher this morning as markets react to a week of elevated geopolitical risk and see-saw headlines around the Middle East conflict. Geopolitical headlines remain at the center of the tape. The conflict in the Middle East has entered its fifth day, with ongoing strikes and counter-strikes keeping energy markets on edge. There are reports Iran has made indirect contact about potential talks, which is feeding some risk appetite and helping futures trim earlier losses, but uncertainty around the durability of any de-escalation continues to drive positioning.The energy complex continues to surge, with crude oil prices well above recent ranges on heightened supply-risk fears tied to the Strait of Hormuz and broader regional tensions. Higher oil is translating into inflation concerns and weighing on multiple risk assets, particularly rate-sensitive sectors that already faced pressure this week.Global equity markets outside the U.S. are showing stress, with Asian markets taking a particularly severe hit. South Korea's benchmark index experienced one of its largest historical selloffs and other major Asian indices like Japan's Nikkei and Taiwan's TAIEX are trading materially lower as well.In pre-market trading, S&P 500 futures rose 0.38%, Nasdaq futures rose 0.59% and Dow futures rose 0.27%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -SSR Miningup 17% after announcing that it has entered into a binding memorandum of understanding to sell its 80% ownership stake in the Copler mine and related properties in Turkey for $1.5BModernaup 8% after entering into a settlement agreement with Arbutus Biopharmaand Genevant Sciences, a subsidiary of Roivant Sciences, resolving all litigation worldwideUP AFTER EARNINGS -Ross Storesup 6%Brown-Formanup 6%Bath & Body Worksup 4%Wix.comup 1%DOWN AFTER EARNINGS -Staar Surgicaldown 8%Abercrombie & Fitchdown 5%Daktronicsdown 4%National Visiondown 1%
Trade with 70% Backtested Accuracy
Analyst Views on MRNA
About MRNA
About the author

- Vaccine Development Progress: Moderna is collaborating with the U.S. Army Medical Research Institute of Infectious Diseases to develop a hantavirus vaccine in early stages, although availability may take years, reflecting the company's commitment to addressing emerging infectious diseases.
- Positive Market Reaction: Moderna's shares rose approximately 14% in Friday afternoon trading, indicating investor optimism regarding the new vaccine development, which could enhance its market competitiveness.
- Epidemic Context Impact: Hantavirus has gained renewed attention due to an outbreak on the MV Hondius cruise ship, which resulted in three deaths and at least six infections, highlighting the urgency for vaccine development as noted by the World Health Organization.
- Funding Challenges and Outlook: Despite the challenges of insufficient funding for hantavirus vaccine development, experts suggest that without significant government investment, the timeline for vaccine availability could extend to a decade or more, impacting the company's long-term strategic planning.
- Market Reaction: The hantavirus outbreak has triggered investor interest, leading biotech stocks like Moderna, Novavax, and Inovio to rise significantly over the past week, reflecting market sensitivity to vaccine development and speculative sentiment.
- CDC Risk Assessment: The Centers for Disease Control and Prevention (CDC) has stated that the risk of hantavirus transmission is extremely low, emphasizing that infection requires close contact with an infected person, which alleviates some market fears and reduces panic.
- Moderna's Development Update: Moderna announced it is working on a hantavirus treatment, currently in early stages, but its stock surged due to market confidence in its mRNA platform, demonstrating ongoing investor interest in vaccine development.
- Cautious Investor Sentiment: Despite the short-term rise in biotech stocks driven by the outbreak, analysts note that these market fluctuations are sentiment-driven and do not reflect fundamentals, urging investors to be cautious and avoid following the hype blindly.
- Market Performance: The S&P 500 rose by 0.17% and the Nasdaq 100 reached an all-time high, reflecting strong corporate earnings and optimism around AI, although rising oil prices and bond yields limited gains.
- Middle East Impact: The failure of the U.S. and Iran to reach a peace agreement has led to rising global bond yields, with the 10-year Treasury yield increasing to 4.39%, potentially forcing central banks to tighten monetary policy, which could affect market liquidity.
- Chinese Trade Data: China's April exports rose 14.1% year-on-year and imports increased by 25.3%, both exceeding market expectations, providing a positive signal for global economic growth and potentially boosting international investment sentiment.
- Corporate Earnings Situation: So far, 83% of the 446 S&P 500 companies have exceeded earnings expectations, with Q1 earnings projected to grow by 12% year-on-year, demonstrating corporate resilience in the economic recovery, although growth in the tech sector has slowed to 3%.
- Earnings Beat: monday.com (MNDY) reported Q1 revenue of $351.3 million, a 24% year-over-year increase that exceeded analyst expectations, showcasing the company's strong performance and growth potential in the market.
- Strategic Shift: Leadership highlighted the transition to consumption-based pricing and the successful rollout of its AI Work Platform as key drivers, which not only enhanced customer satisfaction but also strengthened competitive positioning in the market.
- Operational Leverage: CFO Eliran Glazer noted that internal AI productivity gains allow the company to scale revenue without increasing headcount, indicating a higher operational efficiency achieved in a complex environment.
- Strong Cash Flow: The firm generated over $102 million in adjusted free cash flow, providing substantial capital to further invest in autonomous AI agents, thereby enhancing the sustainability of future growth.
- Healthcare Stock Surge: Healthcare stocks are rising in premarket trading on Monday, indicating a positive sentiment in the market, likely influenced by investor optimism regarding potential healthcare policy changes.
- Positive Market Reaction: The increased attention on the healthcare sector may stem from recent discussions around health-related policies, which are expected to drive growth in healthcare spending and enhance profitability for related companies.
- Selective Investment in Sector: As healthcare stocks rise, investors may reassess their portfolios, increasing allocations to the healthcare sector to seek better risk-adjusted returns amid future market volatility.
- Policy Impact Potential: Potential changes in healthcare policy could present new growth opportunities for healthcare stocks, particularly in the fields of innovative drugs and medical technologies, further boosting market confidence in the sector.
- Pharma Stock Surge: Following the WHO's May 2 warning about the hantavirus outbreak, Moderna's stock rose 7% in premarket trading, indicating market confidence in its ability to address emerging infectious diseases.
- Research Collaboration: Moderna is conducting preclinical research on hantaviruses in collaboration with the US Army Medical Research Institute, although Evercore ISI believes this will not lead to significant revenue opportunities, it highlights the agility of its mRNA platform.
- Other Companies' Performance: Inovio Pharmaceuticals jumped 11% in early trading, while Novavax rose 5%, reflecting positive market sentiment towards vaccine development firms, despite limited overall market opportunities.
- Epidemic Control Status: President Trump stated that the outbreak on the cruise ship is under control, with the WHO reporting 8 confirmed cases and 3 deaths, assessing the public health risk as low, indicating the situation is manageable.











